Kidney Cancer Drug Updates
At an international oncology meeting, new data has been presented on drugs that treat kidney cancer. The results have been released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Tivozanib for Advanced Kidney Cancer
Right now, there are only a handful of drugs that are approved to treat advanced renal cell carcinoma – a type of kidney cancer. Phase 3 clinical trial results of another drug suggest kidney cancer patients may soon have a new option.
Saving Critical Surgical Minutes
Blood flow to the kidney has to be stopped while a cancer tumor is being removed. And those minutes are critical. So kidney cancer surgery involves a race against time.
Kidney Cancer Rx Approved in Europe
Kidney cancer doesn’t usually have any warning signs until it has become pretty serious. In fact, about a third of patients are diagnosed with an advanced stage of the disease. A medication has been approved in Europe to treat kidney cancer that has spread.
The Long and Winding Cancer Clinical Trial Road
The clinical trial process is a long and winding road that has lots of twists and turns. Clinical trials comparing two kidney cancer drugs illustrate this beautifully.
Drugs May Fight Two Dismal Cancers
The development of a new cancer drug involves many years and millions of dollars. That’s one of the reasons why scientists are looking at new uses for existing drugs and combining approved drugs. This approach may work well in treating two really bad cancers.
Depression Can Shorten Lives
Being diagnosed with any advanced cancer is not happy news. So becoming depressed might be a natural response, but it's not a life-prolonging one.
Dualing Against Kidney and Breast Cancer
A lot is being done these days with combining medications, or changing the order in which they're taken. A new dual approach appears to be effective against deadly dual cancers. And the findings may apply to a number of cancers.
ED Tied to Total Kidney Removal
Kidney removal is a serious surgery that comes with some long-term risks, including chronic kidney disease. Now researchers have found it may have an impact on men's sex lives.
One-a-Day Drinkers May Have Lower Kidney Cancer Risks
Kidney cancer isn't all that common. Only about 1 percent of the general population actually develops the disease. And moderate drinkers may not be in that statistic.